• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

People with benign skin condition willing to trade time, money to cure disorder

Bioengineer by Bioengineer
May 20, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

New study highlights the substantial effect that condition has on quality of life

(Boston)–People with benign hyperpigmentation (the darkening or increase in the natural color of the skin), are willing to pay (WTP) nearly 14 percent of their monthly income and approximately 90 minutes a day to cure their condition.

The study involved 85 adults with skin hyperpigmentation who were surveyed on the number of hours per day they would be willing to give up as well as how much money they were willing to spend to potentially be cured of a condition.

“Our findings highlight the substantial effect that benign hyperpigmentation has on quality of life as measured by the amount of time and money patients are willing to give up to rid themselves of disease,” explained corresponding author Neelam Vashi, MD, assistant professor of dermatology at Boston University School of Medicine and director of the Boston University Cosmetic and Laser Center at Boston Medical Center.

Hyperpigmentation disorders comprise a large group of benign skin conditions and their prevalence may vary with race and ethnicity. Despite often being considered a cosmetic condition, Vashi has shown in her previous research that this common clinical complaint has been shown to negatively impact quality of life and psychosocial well-being of patients, especially when facial skin is involved.

According to the researchers these findings suggest that disease burden was overall severe in patients with hyperpigmentation disorders, and measuring WTP and TTO may be useful in determining the daily impact of disease and treatment preferences. “We found that the WTP for a curative treatment was greater than that previously observed among patients with other skin diseases such as rosacea and vitiligo. This may suggest that hyperpigmentation disorders have a greater impact on daily life or that patients expect to pay more out of pocket for conditions that are often considered cosmetic.”

The researchers point out that although the study is limited by sample size and design, the information collected on WTP preferences allow physicians to gauge the impact of hyperpigmentation disorders on patients’ lives and may be useful to guide therapeutic decisions.

###

These findings appear as a Brief Report in the Journal of Clinical and Aesthetic Dermatology.

Funding for this study was provided by the Boston University Department of Dermatology.

Media Contact
Gina DiGravio
[email protected]

Tags: DermatologyMedicine/Health
Share13Tweet8Share2ShareShareShare2

Related Posts

Obesity’s Effects on Bones: Molecules and Metabolism

September 24, 2025

Trends in Breast Cancer Screening for Older Women

September 24, 2025

Long-Term Durability of Valoctocogene Roxaparvovec in Hemophilia A

September 24, 2025

Triazole-Linked Agrimonolide Derivatives Combat Ulcerative Colitis

September 24, 2025
Please login to join discussion

POPULAR NEWS

  • Physicists Develop Visible Time Crystal for the First Time

    Physicists Develop Visible Time Crystal for the First Time

    69 shares
    Share 28 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    50 shares
    Share 20 Tweet 13
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    49 shares
    Share 20 Tweet 12
  • Rapid Spread of Drug-Resistant Fungus Candidozyma auris in European Hospitals Prompts Urgent Warning from ECDC

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Obesity’s Effects on Bones: Molecules and Metabolism

Electrolytes Impact Graphene Exfoliation and Supercapacitor Efficiency

Trends in Breast Cancer Screening for Older Women

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.